Document reference

2021/2616(DEA)  
Examination of variations to the terms of marketing authorisations for medicinal products for human use and veterinary medicinal products  
Basic information  

2021/2616(DEA)

DEA - Delegated acts procedure

Supplementing 1999/0134(COD)

Subject
3.10.08 Animal health requirements, veterinary legislation and pharmacy
4.20.01 Medicine, diseases
4.20.04 Pharmaceutical products and industry
4.20.05 Health legislation and policy

Status

Procedure completed - delegated act enters into force

 

Please go to Documentation gateway for any follow-up documents.: Please go to Documentation gateway for any follow-up documents. 
Key players  
Key events  
24/03/2021
Non-legislative basic document published
C(2021)01603
24/03/2021
Initial period for examining delegated act 3 month(s)
07/04/2021
Delegated act not objected by Council
27/04/2021
Decision by Parliament
T9-0134/2021
28/04/2021
Committee referral announced in Parliament
Technical information  
Procedure reference
2021/2616(DEA)
Procedure type
DEA - Delegated acts procedure
Procedure subtype
Examination of delegated act
Legal basis
Rules of Procedure EP 0111-p6
Stage reached in procedure
Procedure completed - delegated act enters into force
Committee dossier
ENVI/9/05567
Documentation gateway  
  • European Parliament 
    Recommendation for early non-objection of delegated act
       
    B9-0226/2021  
    23/04/2021
    EP
     
    Text adopted by Parliament, single reading
       
    T9-0134/2021  
    27/04/2021
    EP
     
  • European Commission 
    Non-legislative basic document
     
    C(2021)01603  
    24/03/2021
    EC
     
    Document attached to the procedure
     
    C(2021)4187
    08/06/2021
    EC
     
  • All 
    Non-legislative basic document
       
    C(2021)01603  
    24/03/2021
    EC
     
    Recommendation for early non-objection of delegated act
       
    B9-0226/2021  
    23/04/2021
    EP
     
    Text adopted by Parliament, single reading
       
    T9-0134/2021  
    27/04/2021
    EP
     
    Document attached to the procedure
       
    C(2021)4187
    08/06/2021
    EC